SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is plummeting after its Q2 earnings miss and full-year guidance cut, with the market heavily punishing the sporting goods retailer. Traders are actively debating whether the selloff is an overreaction or the start of a deeper decline, fueled by concerns over weakening consumer spending and the drag from its Foot Locker acquisition.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending due to a sharp post-earnings selloff despite strong revenue growth and raised guidance, with the community fiercely debating whether the drop is an overreaction to accounting losses or a justified response to weak margins and potential dilution.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical minerals/rare earths are ripping on U.S. mining and supply-chain policy momentum, and CRML is catching a strong short-squeeze bid as traders point to CEO media appearances, Tanbreez development progress, and the European Lithium merger as catalysts. Community talk is split between bullish strategic-asset/squeeze narratives and persistent criticism of management, flawed valuation reports, and dilution concerns.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

LULU is trending as traders dissect Michael Burry's bullish call (calling it 'screaming cheap' and adding to his position) alongside expectations of a major EPS boost from tariff refunds and the incoming new CEO. Bulls point to insider buying and a short squeeze potential, while bears highlight analyst downgrades and tariff risks, fueling intense two-sided debate.

Greenland Mines Ltd. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Charlotte, NC.

Greenland Mines Ltd.

GRML is trending on a post-reverse-split surge with a razor-thin float, as traders hype a rare earth project valuation and possible short squeeze while skeptics warn of imminent dilution from a fresh ATM offering.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Retail is piling into Immix Biopharma around a heavily shorted float, chatter about a potential squeeze, and anticipation of the upcoming NXC-201 data readout. Traders are also parsing fresh institutional accumulation and lingering CMO-related overhang while debating whether the bullish setup remains intact.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is plunging to fresh multi-year lows as the athletic sector reels from Dick's Sporting Goods' earnings miss and guidance cut, sparking intense debate about a broken brand, 'go woke go broke' narratives, and whether this is a generational bottom or a value trap.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors weigh its strategic acquisition of Claros, which aims to complete its grid-to-GPU power stack and significantly expand its addressable market against ongoing concerns about patent litigation and short interest. While the community remains divided, many retail traders are focused on the long-term potential of its AI data center power architecture despite recent price volatility.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Community is laser-focused on Hyperliquid's potential US regulatory path after Trump signaled CFTC involvement, with Druckenmiller's disclosed stake and HYPE.X strength adding fuel. Traders are buzzing about a low-float short/gamma squeeze narrative into the upcoming earnings report, while CNBC attention keeps sentiment extremely bullish.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending following an FDA notification of deficiencies in its Anaphylm application, which has paused labeling discussions but is not a final decision. While some investors fear a significant delay or rejection, many view the substantial stock pullback as an overreaction, anticipating that the issues are minor and will be resolved prior to the upcoming PDUFA date. The community is actively debating whether this signals a major setback or a strategic opportunity for eventual approval of the innovative needle-free allergy treatment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ABUS does our Hep B fast track cure have any estimates on the global markets pice on 250 million plus customers ? 
One single treatment of treatment at $1200 x 250 million is 300.7 billion dollars...!! One time treatment for current cases not on going infection... That&#39;s a pretty modest cost at 1,200 in my opinion not sure the real price for treatment sales. Just thoughts..

Isaac Diaz

Michael Heavey

John

Shannon Ware

John Ryan

Hawktwits70

Abus4ever

StockTwits Web

Arbutus Biopharma Corp

 does our Hep B fast track cure have any estimates on the global markets pice on 250 million plus customers ? 
One single treatment of treatment at $1200 x 250 million is 300.7 billion dollars...!! One time treatment for current cases not on going infection... That's a pretty modest cost at 1,200 in my opinion not sure the real price for treatment sales. Just thoughts..

Can we assume LNP technology is worth 25 billion in licensing as well with the recent $MRNA case  cancer use. With them gaining 100 billion in value. If it&#39;s not with them or a competitor.. 
 
Let&#39;s just cut everything in half 150 billion for Hep B, plus 12 billion LNP license, plus 2-6 billion in litigation solidified. Total $170 billion+-...? Possible.. IDK.. 
$JNJ  I think is sniffing around.. I hope

Moderna Inc

Johnson & Johnson

Can we assume LNP technology is worth 25 billion in licensing as well with the recent 

 case  cancer use. With them gaining 100 billion in value. If it's not with them or a competitor.. 
 
Let's just cut everything in half 150 billion for Hep B, plus 12 billion LNP license, plus 2-6 billion in litigation solidified. Total $170 billion+-...? Possible.. IDK.. 
